연구성과로 돌아가기
2021 연구자 정보 (37 / 1146)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Nellist, Peter D. (Nellist, PD) |
Univ Oxford, Dept Mat, Oxford OX1 3PH, England |
|
|
[JCR상위 2.1] Significant Performance Improvement in n-Channel Organic Field-Effect Transistors with C60:C70 Co-Crystals Induced by Poly(2-ethyl-2-oxazoline) Nanodots | SCIE | 2.1 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | ykimm@knu.ac.kr;thomas.anthopoulos@kaust.edu.sa;donal.bradley@physics.ox.ac.uk; | ||
|
Noh, Siwoo (Noh, S) |
POSTEC, Pohang Accelerator Lab, Pohang 37673, Gyeongsangbuk D, South Korea |
|
|
[JCR상위 2.1] Crystal Phase Transition Creates a Highly Active and Stable RuCX Nanosurface for Hydrogen Evolution Reaction in Alkaline Media | SCIE | 2.1 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | hklim@kangwon.ac.kr;ysyoun@yu.ac.kr;sichoi@knu.ac.kr; | ||
|
Varambhia, Aakash (Varambhia, A) |
Univ Oxford, Dept Mat, Oxford OX1 3PH, England |
|
|
[JCR상위 2.1] Significant Performance Improvement in n-Channel Organic Field-Effect Transistors with C60:C70 Co-Crystals Induced by Poly(2-ethyl-2-oxazoline) Nanodots | SCIE | 2.1 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | ykimm@knu.ac.kr;thomas.anthopoulos@kaust.edu.sa;donal.bradley@physics.ox.ac.uk; | ||
|
Yoon, Sun Geun (Yoon, SG) |
Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Program Nano Sci & Technol, Seoul 08826, South Korea |
|
0000-0002-6222-8962 Yoon, Sun Geun |
[JCR상위 2.1] Electron Density-Change in Semiconductor by Ion-Adsorption at Solid-Liquid Interface | SCIE | 2.1 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | younskim@snu.ac.kr; | ||
|
Youn, Young-Sang (Youn, YS) |
교신저자 | Yeungnam Univ, Dept Chem, Gyongsan 38541, Gyeongsangbuk D, South Korea |
|
0000-0003-4201-3152 Youn, Young-Sang |
[JCR상위 2.1] Crystal Phase Transition Creates a Highly Active and Stable RuCX Nanosurface for Hydrogen Evolution Reaction in Alkaline Media | SCIE | 2.1 | CHEMISTRY, MULTIDISCIPLINARY;CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED;PHYSICS, CONDENSED MATTER | hklim@kangwon.ac.kr;ysyoun@yu.ac.kr;sichoi@knu.ac.kr; | |
|
Anthony Dacosta, Noshir (Dacosta, NA) |
|
|
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY | ||||
|
Bae, Ki Beom (Bae, KB) |
|
|
[JCR상위 2.2] Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial. | SCIE | 2.2 | ONCOLOGY | ||||
|
Baek, Seong Kyu (Baek, SK) |
|
|
[JCR상위 2.2] Clinical efficacy and safety of early adjuvant chemotherapy for stage III colon cancer: Short-term outcomes of a multicenter, randomized, open-label, phase 3 trial. | SCIE | 2.2 | ONCOLOGY | ||||
|
Beom, Seung-Hoon (Beom, SH) |
Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Bondarenko, Igor (Bondarenko, I) |
U-5156-2017 Bondarenko, Igor |
0000-0002-7071-2471 Bondarenko, Igor |
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY | ||||
|
Chic, Nuria (Chic, N) |
|
|
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY | ||||
|
Cho, Sang Hee (Cho, SH) |
Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Med Sch, Jeonnam, South Korea |
|
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Choi, Jin-Hyuk (Choi, JH) |
Ajou Univ, Dept Hematol Oncol, Sch Med, Suwon, South Korea |
S-1679-2017 Choi, Jin |
|
[JCR상위 2.2] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | SCIE | 2.2 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Chung, Chi-Feng (Chung, CF) |
|
|
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY | ||||
|
Gomez, Patricia (Gomez, P) |
JFB-3275-2023 GÓMEZ, PATRICIA |
|
[JCR상위 2.2] Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane. | SCIE | 2.2 | ONCOLOGY |
페이지 이동: